Bryan Hanson
New CEO Hanson, appointed to Zimmer Biomet in 2017, aims to turn the company around with a strong team, but faces regulatory challenges outside his control.
Interviews highlight Hanson's strong leadership, directly applicable experience, and competitive nature as key to addressing Zimmer's merger, operational, and regulatory issues.
While Hanson's ethics are praised, some sources noted his tolerance for questionable behavior if it avoided business disruption, adding complexity to his leadership profile.
By submitting this form, you are agreeing to ManagementTrack’s Privacy Policy. You can choose to opt out of marketing or advertising emails using the ‘unsubscibe’ link included in our emails.
The best
The best
The best
Our investigative journalists interview the top former colleagues of the CEOs you care about.
Our former buysider analysts summarize the key strengths & weaknesses, past successes & failures, and ability to drive value going forward.
You get access to the actual anonymized transcripts and insights.